Professor Margaret Frame
Prof Margaret Frame (OBE) is a Professor of Cancer Research at the University of Edinburgh and the Director of the Institute of Genetics and Cancer.
Prof Frame has a background in biochemistry and molecular pathology. Her research focuses on protein networks biology and functions of cell-adhesion proteins in the context of cancer. A key feature of her lab’s work during the recent past has been to embrace inter-disciplinary team science that brings new innovative approaches to cancer biology questions. The overarching aims of her research are: (i) mapping cancer phenotypes on to cancer pathways, using mouse- and human patient-derived material as biological source; and (ii) to improve the predictivity of pre-clinical therapeutic testing. She has a special interest in inter-disciplinary doctoral and post-doctoral training, and the support and mentoring of all early- and mid-career researchers.
She serves (or served) on multiple decision-making bodies and in other advisory/management roles. Current and past examples include: President of the British Association for Cancer Research (BACR; from Jan 2016); AACR/CRUK – “Stand Up For Cancer“: panel 2014; European Research Council (ERC) Starter grants panel : sub-panel LS3; Chair: Academy of Medical Sciences, Genetics, Cellular and Developmental Biology, Microbiology and Immunology Panel; Royal Society of Edinburgh, Cell and Molecular Biology Panel; Chair: Cancer Research UK (CR-UK), New Investigator Panel; Cancer Research UK, Training and Career Development Board; Cancer Research UK, Science Strategy Advisory Group; Cross UK-North America Cancer Imaging Alliance – joint initiative between CR-UK, NCI-USA and Canadian Institutes of Health Research’s Institute of Cancer Research (CIHR-ICR); Wellcome Trust, Genes, Molecules and Cells Panel; Advisory/Review Boards for several European Institutions: Oslo Centre for Biotechnology, University of Basel, Department of Biomedizine, Karolinska Institute Cancer Appointments Advisory Board, FP7 ‘Molecular Oncology Pathways’ Turin Advisory Board, Marseilles Institute of Biology, France, Bristol Myers Squibb, Europe and USA; membership in several University of Edinburgh (UoE) committees (including: Institute of Genetics and Cancer (IGC) Executive, IGC Science Translational Strategy Group (Chair), CRUK Edinburgh Centre Governance Board, College of Medicine and Veterinary Medicine (CMVM) Strategy Group, UoE: Research Planning Group).
Margaret Frame Group website